Plasticell is a pioneering biotechnology company that specialises in the differentiation of stem cells to obtain cell types for a range of biomedical applications. Founded in 2002, Plasticell has assembled an outstanding team of scientists with longstanding expertise in stem cell research, particularly in directed stem cell differentiation. The company is advised by an eminent Scientific Advisory Board that includes two Nobel laureates.

Plasticell’s proprietary, award-winning technology, Combinatorial Cell Culture (CombiCult™), is a bead-based high throughput screening platform developed specially for use in stem cell research. Using this technology Plasticell has successfully differentiated embryonic and adult stem cells into a variety of hard-to-obtain somatic lineages on behalf of numerous leading biotechnology and pharmaceutical industry clients.

Plasticell’s business model is to provide services to companies that wish to produce cells for research, and to form alliances with companies that manufacture cells for therapy.